XBI
State Street SPDR S&P Biotech ETF · Financial Services · Asset Management
Momentum-Eingaben (vergleichbare Manager):
Halterbreite -18.2% ·
Aktienfluss -0.5% ·
neue Nettopositionen -20.0%
— Formel
Breite Distribution — sinkende Anteile und weniger Halter
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q3 2025
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 93 | +4 | 100.80M | $15.95B | +7 | −3 |
| Q1 2026 | 90 | +1 | 110.09M | $14.00B | +3 | −2 |
| Q4 2025 | 88 | +1 | 111.38M | $13.58B | +2 | −1 |
| Q3 2025 | 9 | -2 | 60.81M | $6.09B | +1 | −3 |
| Q2 2025 | 8 | 0 | 709.53K | $58.84M | +1 | −1 |
| Q1 2025 | 6 | 0 | 732.41K | $59.40M | +1 | −1 |
| Q4 2024 | 6 | +1 | 1.37M | $123.50M | +2 | −1 |
| Q3 2024 | 5 | 0 | 1.78M | $175.82M | +1 | −1 |
| Q2 2024 | 5 | — | 460.49K | $42.69M | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | JPMorgan Chase ✦ | 27.08M | — | $2.71B | 0.1% | n/c | 1 | SEC ↗ |
| 2 | JPMorgan Chase ✦ | 27.08M | — | $2.71B | 0.1% | n/c | 1 | SEC ↗ |
| 3 | JPMorgan Chase ✦ | 27.08M | — | $2.71B | 0.1% | n/c | 1 | SEC ↗ |
| 4 | JPMorgan Chase ✦ | 27.08M | — | $2.71B | 0.1% | n/c | 1 | SEC ↗ |
| 5 | JPMorgan Chase ✦ | 27.08M | — | $2.71B | 0.1% | n/c | 1 | SEC ↗ |
| 6 | JPMorgan Chase ✦ | 27.08M | — | $2.71B | 0.1% | n/c | 1 | SEC ↗ |
| 7 | JPMorgan Chase ✦ | 27.08M | — | $2.71B | 0.1% | n/c | 1 | SEC ↗ |
| 8 | JPMorgan Chase ✦ | 27.08M | — | $2.71B | 0.1% | n/c | 1 | SEC ↗ |
| 9 | JPMorgan Chase ✦ | 27.08M | — | $2.71B | 0.1% | n/c | 1 | SEC ↗ |
| 10 | JPMorgan Chase ✦ | 27.08M | — | $2.71B | 0.1% | n/c | 1 | SEC ↗ |
| 11 | JPMorgan Chase ✦ | 27.08M | — | $2.71B | 0.1% | n/c | 1 | SEC ↗ |
| 12 | JPMorgan Chase ✦ | 27.08M | — | $2.71B | 0.1% | n/c | 1 | SEC ↗ |
| 13 | Goldman Sachs Group ✦ | 22.73M | — | $2.28B | 0.3% | n/c | 1 | SEC ↗ |
| 14 | Goldman Sachs Group ✦ | 22.73M | — | $2.28B | 0.3% | n/c | 1 | SEC ↗ |
| 15 | Morgan Stanley ✦ | 10.61M | — | $1.06B | 0.1% | n/c | 1 | SEC ↗ |
| 16 | Morgan Stanley ✦ | 10.61M | — | $1.06B | 0.1% | n/c | 1 | SEC ↗ |
| 17 | Morgan Stanley ✦ | 10.61M | — | $1.06B | 0.1% | n/c | 1 | SEC ↗ |
| 18 | Morgan Stanley ✦ | 10.61M | — | $1.06B | 0.1% | n/c | 1 | SEC ↗ |
| 19 | Morgan Stanley ✦ | 10.61M | — | $1.06B | 0.1% | n/c | 1 | SEC ↗ |
| 20 | Morgan Stanley ✦ | 10.61M | — | $1.06B | 0.1% | n/c | 1 | SEC ↗ |
| 21 | Morgan Stanley ✦ | 10.61M | — | $1.06B | 0.1% | n/c | 1 | SEC ↗ |
| 22 | BlackRock ✦ (passiv) | 255.78K | +11.0% | $25.63M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 23 | BlackRock ✦ (passiv) | 255.78K | +11.0% | $25.63M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 24 | BlackRock ✦ (passiv) | 255.78K | +11.0% | $25.63M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 25 | Millennium Management ✦ | 74.72K | -76.6% | $7.49M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 26 | Marshall Wace ✦ | 34.29K | +752.4% | $3.44M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 27 | Two Sigma Investments ✦ | 8.30K | Neu | $831,660 | 0.0% | New | 1 | SEC ↗ |
| 28 | AQR Capital Management ✦ | 7.39K | +8.5% | $740,343 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 29 | AQR Capital Management ✦ | 7.39K | +8.5% | $740,343 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 30 | Fidelity (FMR) ✦ | 6.58K | +15.2% | $659,746 | 0.0% | ▲ Add | 2 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Two Sigma Investments | $831,660 | 0.0% |
Ausgestiegen
| D. E. Shaw & Co. | $5.15M | war 0.0% |
| Renaissance Technologies | $4.05M | war 0.0% |
| Citadel Advisors | $2.65M | war 0.0% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 811 Inhaber, 125.00M Anteile, $15.39B gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.